View of Targeting the IL-33/ST2 signalling pathway as a therapeutic strategy for the treatment of multiple inflammatory diseases

Return to Article Details Targeting the IL-33/ST2 signalling pathway as a therapeutic strategy for the treatment of multiple inflammatory diseases Download Download PDF